Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
T(4) is standard treatment for hypothyroidism. A recent study reported that combined T(4)/liothyronine (T(3)) treatment improved well-being and cognitive function compared with T(4) alone. We conducted a double-blind, randomized, controlled trial with a crossover design in 110 patients (101 completers) with primary hypothyroidism in which liothyronine 10 micro g was substituted for 50 micro g of the patients' usual T(4) dose. No significant (P < 0.05) difference between T(4) and combined T(4)/T(3) treatment was demonstrated on cognitive function, quality of life scores, Thyroid Symptom Questionnaire scores, subjective satisfaction with treatment, or eight of 10 visual analog scales assessing symptoms. For the General Health Questionnaire-28 and visual analog scales assessing anxiety and nausea, scores were significantly (P < 0.05) worse for combined treatment than for T(4) alone. Serum TSH was lower during T(4) treatment than during combined T(4)/T(3) treatment (mean +/- SEM, 1.5 +/- 0.2 vs. 3.1 +/- 0.2 mU/liter; P < 0.001), a potentially confounding factor; however, subgroup analysis of subjects with comparable serum TSH concentrations during each treatment showed no benefit from combined treatment compared with T(4) alone. We conclude that in the doses used in this study, combined T(4)/T(3) treatment does not improve well-being, cognitive function, or quality of life compared with T(4) alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas patients from another trial incorporating 101 patients had no treatment preference (52).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [52]
In the citing paper
“Some trials have excluded specific patient groups, such as those with mental illness, affective disorders, or untreated depression (48,49,52).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [52]
In the citing paper
“Three trials of synthetic combination therapy (17,47,52) and one of DTE (58) have used thyroid-specific PROs.”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [52]
In the citing paper
“Where measured, bone turnover markers (alkaline phosphatase, osteocalcin, and urinary deoxypyridinolines) were increased in two trials (including the Appelhof trial arm using the 5:1 LT4:LT3 ratio) (53,78), and no different in two trials (49,52).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [52]
In the citing paper
“A crossover design is appealing because of the increase in statistical power due to the ability to perform paired analyses, as has been performed in prior studies (23,46,50,52,58,59,75,76,107).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [52]
30 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
A compendium of neuropsychological tests: administration, norms, and commentary
(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,120
(1988) · NFER-Nelson eBooks · Cited by 5,560
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,459
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Levin, H. S. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050007005 · Cited by 4,766
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Turner‐Bowker, D. M., DeRosa, M., & Ware, J. E. (2008) · eScholarship@UMassChan · Cited by 954
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 1×
“99 mU/liter or more in the same (euthyroid) individual on two occasions, the difference is statistically significant at the 1% level (28).”
BackgroundSaravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 14×
“Dissatisfied subjects tended to be younger than satisfied subjects and had significantly worse quality of life (determined by SF-36) and more symptoms and signs of hypothyroidism (as determined by TSQ and Zulewski score).”
MethodInfluentialBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 10×
“74 4546 J Clin Endocrinol Metab, October 2003, 88(10):4543–4550 Walsh et al.”
BackgroundMethodInfluentialDemers, L. M., & Spencer, C. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01681.x · Cited by 460
Bianco, A. C. (2002) · Endocrine Reviews · doi:10.1210/er.23.1.38 · Cited by 423
Thyroid-Pituitary Interaction: Feedback Regulation of Thyrotropin Secretion by Thyroid Hormones
Bleich, H. L., Moore, M. J., & Larsen, P. R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201073060107 · Cited by 357
Fish, L. H., Schwartz, H. L., Cavanaugh, J., Steffes, M. W., Bantle, J. P., & Oppenheimer, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161302 · Cited by 353
Zulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 338
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261 · cited 1×
“thyroidectomy and radioiodine treatment, T4 alone failed to normalize circulating and tissue concentrations of T4 and T3, but this was achieved with combined T4/T3 treatment (8, 9).”
BackgroundZulewski, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.771 · Cited by 211
CARR, D., MCLEOD, D. T., PARRY, G., & THORNES, H. M. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb01219.x · Cited by 210
Pilo, A., Iervasi, G., Vitek, F., Ferdeghini, M., Cazzuola, F., & Bianchi, R. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.4.e715 · Cited by 185
Normative data for the Halstead-Reitan neuropsychological tests stratified by age and sex
Yeudall, L. T., Reddon, J. R., Gill, D. M., & Stefanyk, W. O. (1987) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198705)43:3<346::aid-jclp2270430308>3.0.co;2-q · Cited by 160
Thyroid Hormone Replacement Therapy
Wiersinga, W. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048140 · Cited by 148
3:5:3′-Triiodothyronine. 2. Physiological activity
Gross, J., & Pitt‐Rivers, R. (1953) · Biochemical Journal · doi:10.1042/bj0530652 · Cited by 119
The Use and Misuse of Thyroid Hormone*
ROTI, E., MINELLI, R., GARDINI, E., & BRAVERMAN, L. E. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-401 · Cited by 109
Smith, R. N., Taylor, S. A., & Massey, J. C. (1970) · BMJ · doi:10.1136/bmj.4.5728.145 · Cited by 106 · cited 1×
“combined T4/T3 treatment with T4 alone and found that T4 was better tolerated (7); however, the doses of both T4 and T3 that were used would now be regarded as excessive.”
BackgroundKent, G. N., Stuckey, B. G. A., Allen, J. R., Lambert, T., & Gee, V. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00807.x · Cited by 93
Self-citationMr. Randall, A. G., Kent, G. N., Garcia-Webb, P., Bhagat, C. I., Pearce, D. J., Gutteridge, D. H., Prince, R. L., Stewart, G., Stuckey, B., Will, R. K., et al. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110817 · Cited by 74
Self-citationTHE PHYSIOLOGIC ACTIVITY OF Z-TRIIODOTHYRONINE*
LERMAN, J. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-11-1341 · Cited by 71
Psychological wellbeing in patients
Ladenson, P. W. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01682.x · Cited by 59
THE ACHILLES REFLEX A DIAGNOSTIC TEST OF THYROID DYSFUNCTION
SHERMAN, L., GOLDBERG, M., & LARSON, F. C. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90953-x · Cited by 57
Dissatisfaction with thyroxine therapy — could the patients be right?
Walsh, J. P. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00209-6 · Cited by 49
Self-citationAbsorption of Triiodothyronine in Man
HAYS, M. T. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-5-675 · Cited by 47
Thyroid Hormone Replacement — One Hormone or Two?
Toft, A. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400611 · Cited by 45
The use and misuse of thyroid hormone
Roti, E. (1993) · Endocrine Reviews · doi:10.1210/er.14.4.401 · Cited by 26
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“(385), respectively, or (iii) no significant difference between treatment groups in seven trials (384,517,518, 520,522–524).”
InfluentialChaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Roberts, C. G., & Ladenson, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15696-1 · Cited by 567
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Metadata
- Authors
- Walsh, J. P., Shiels, L., Lim, E. M., Bhagat, C. I., Ward, L. C., Stuckey, B. G. A., Dhaliwal, S. S., Chew, G. T., Bhagat, M. C., & Cussons, A. J.
- Affiliations
- Sir Charles Gairdner Hospital (AU)
- Corresponding author
- Walsh, John P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-10
- Volume
- 88
- Issue
- 10
- Pages
- 4543-4550
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2151046347
- Cited by
- 210
- References
- 33
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 10 · 2016: 13 · 2015: 6 · 2014: 9 · 2013: 5 · 2012: 12
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- primary hypothyroidism, liothyronine, thyroxine, thyroid hormone replacement, cognitive function, quality of life, well-being, thyroid symptoms, serum TSH, anxiety, nausea, treatment satisfaction
- MeSH terms
- Adult, Blood Pressure, Cognition, Double-Blind Method, Drug Therapy, Combination, Female, Heart Rate, Humans, Hypothyroidism, Male, Middle Aged, Patient Compliance, Quality of Life, Reflex, Thyroxine, Triiodothyronine, Patient Satisfaction, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.